PRESS RELEASE May 23, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that the results.
PRESS RELEASE May 23, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that the results from the randomized controlled clinical
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Saniona Launches New Video Series to Highlight the Impact of Prader-Willi Syndrome and .
Saniona ABMay 10, 2021 GMT
PRESS RELEASE
May 10, 2021
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced its “Saniona’s Community Voices” video series, which will feature the voices of people living with rare diseases, their caregivers and their medical professionals. The series will launch during the month of May, which is both Prader-Willi syndrome (PWS) and Brain Tumor Awareness Month and will begin by spotlighting the impact of these conditions on patients and their families.
Saniona Announces Oral Presentation of Tesomet Data in Hypothalamic Obesity at ENDO 2021 apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.